Denali Therapeutics Inc.

Direct answer

Denali Therapeutics Inc. is publicly traded on NASDAQ under the ticker DNLI.

Denali Therapeutics Inc. is a biopharmaceutical firm, founded in 2013 and based in South San Francisco, California, which focuses on identifying and advancing treatments for neurodegenerative conditions within the United States. The company, initially known as SPR Pharma Inc. until its renaming in March 2015, possesses a robust development pipeline. This includes BIIB122/DNL151, a small molecule inhibitor targeting...

Can you invest in Denali Therapeutics Inc.?

Yes. Denali Therapeutics Inc. is publicly traded on NASDAQ under the ticker DNLI.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Denali Therapeutics Inc.

Detailed equity research is provided by MarketSnap.